Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KCK Medtech is a venture capital firm established to invest in the medical technology sector. Founded by a team of former operators with extensive experience in leadership roles at Fortune 500 companies and startups, KCK Medtech focuses on enhancing healthcare standards through strategic partnerships with innovative medical technology companies. The firm operates globally, emphasizing its commitment to improving healthcare through advanced medical devices.
As an evergreen fund, KCK Medtech provides flexible and long-term capital, allowing it to engage actively with portfolio companies without the constraints of traditional funding timelines. This structure supports a commitment to long-term value creation and enables the firm to address challenges within its investments effectively. KCK Medtech's operator-led team brings hands-on industry experience, which is crucial for navigating the complexities of the medtech landscape.
KCK Medtech invests primarily in revolutionary medical device companies across various stages, including Seed, Series A, Series B, and Growth Equity. The firm targets healthcare, biotech, and medical devices sectors, seeking to back companies with differentiated products that can disrupt or create large markets. KCK Medtech emphasizes the importance of strong management teams and defensible business models in its investment decisions.
The evergreen fund structure allows KCK Medtech to provide flexible capital, which is particularly advantageous in the medtech sector, where development timelines can be lengthy. The firm actively engages in identifying talent and solving challenges within its portfolio, ensuring that its investments are well-positioned for long-term success. KCK Medtech's investment strategy is characterized by a commitment to fostering innovation and improving healthcare standards through its portfolio companies.
KCK Medtech's portfolio includes 14 notable companies, each contributing to advancements in medical technology:
Greg Garfield: Sr. Managing Director with extensive experience in the medical technology sector, having held leadership roles in both startups and Fortune 500 companies.
Karen Long: Sr. Managing Director known for her expertise in operational management and strategic growth within the medtech industry.
John White: Managing Director with a strong background in investment and operational roles, focusing on innovative medical device companies.
Susan Stimson: Managing Director who brings a wealth of experience in healthcare investments and operational excellence.
Dan Harfe: Principal with a focus on identifying and supporting emerging medical technology startups.
Chase Garfield: Analyst who assists in evaluating investment opportunities and conducting market research.
To pitch KCK Medtech, founders should visit their website at kckmedtech.com. It is recommended to include a comprehensive pitch deck that outlines the product, market analysis, competitive landscape, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
As of April 2023, KCK Medtech has continued to expand its portfolio, which now includes 14 notable medical technology companies. The firm remains committed to improving healthcare standards through innovative solutions in the medical device space.
Recent highlights include the successful advancements of portfolio companies such as NeuroPace and Sight Sciences, which have made significant strides in their respective fields. KCK Medtech's operator-led team has been actively involved in supporting these companies through strategic guidance and operational insights.
What are KCK Medtech's investment criteria?
KCK Medtech focuses on investing in medical device companies that have differentiated products capable of disrupting or creating large markets. The firm looks for strong management teams and defensible business models.
How can I pitch to KCK Medtech?
Founders can pitch their ideas through the official website at kckmedtech.com. It is advisable to include a clear overview of the product, market potential, and the team’s background in the pitch deck.
What makes KCK Medtech different from other investors?
KCK Medtech operates as an evergreen fund, allowing for flexible and long-term capital without the pressures of traditional funding timelines. This structure enables the firm to engage actively with its portfolio companies.
What is KCK Medtech's geographic scope?
The firm invests globally, focusing on innovative medical technology companies regardless of their location.
What type of support does KCK Medtech provide to its portfolio companies?
KCK Medtech adds value through its operator-led team, which offers hands-on industry experience, talent identification, and problem-solving support to foster long-term growth.
What is the typical check size for investments?
While specific check sizes are not disclosed, KCK Medtech invests across various stages, including Seed, Series A, Series B, and Growth Equity, indicating a range of investment amounts depending on the stage and needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.